SOX9 and treatment resistant depression: Furthermore, there was no difference in the expression of the proliferation marker Ki-67 or the expression of different members of the Wnt signaling pathway (Cyclin-D1, β-catenin, E-cadherin or SOX9) between TRD-treated animals and the control group.